Yingbin Luo

530 total citations
24 papers, 438 citations indexed

About

Yingbin Luo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yingbin Luo has authored 24 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Yingbin Luo's work include Immune cells in cancer (5 papers), Cancer Mechanisms and Therapy (3 papers) and MicroRNA in disease regulation (3 papers). Yingbin Luo is often cited by papers focused on Immune cells in cancer (5 papers), Cancer Mechanisms and Therapy (3 papers) and MicroRNA in disease regulation (3 papers). Yingbin Luo collaborates with scholars based in China. Yingbin Luo's co-authors include Jianchun Wu, Zhihong Fang, Jianhui Tian, Wenjing Teng, Yan Li, Nan Huang, Xiaohui Yang, Honglin Li, Min Chen and Yuli Wang and has published in prestigious journals such as Oncotarget, Oxidative Medicine and Cellular Longevity and Current Pharmaceutical Design.

In The Last Decade

Yingbin Luo

22 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingbin Luo China 11 253 116 112 102 90 24 438
Shreya Kar Singapore 6 290 1.1× 101 0.9× 98 0.9× 138 1.4× 42 0.5× 8 500
Xiaokun Yang China 12 238 0.9× 122 1.1× 59 0.5× 82 0.8× 110 1.2× 30 445
Deok Yong Sim South Korea 15 332 1.3× 123 1.1× 57 0.5× 100 1.0× 43 0.5× 39 497
Fengjun Cao China 16 355 1.4× 136 1.2× 63 0.6× 127 1.2× 70 0.8× 23 589
Weili Min China 17 299 1.2× 110 0.9× 45 0.4× 132 1.3× 92 1.0× 26 591
Jianyong Xiao China 15 370 1.5× 114 1.0× 56 0.5× 91 0.9× 46 0.5× 26 560
Jing Ying Wang China 14 325 1.3× 134 1.2× 94 0.8× 157 1.5× 32 0.4× 19 612
Xuming Ji China 12 238 0.9× 53 0.5× 48 0.4× 91 0.9× 58 0.6× 35 388
Kaikai Yu China 10 229 0.9× 80 0.7× 111 1.0× 45 0.4× 76 0.8× 22 440
Wenjing Teng China 9 252 1.0× 124 1.1× 67 0.6× 61 0.6× 82 0.9× 16 418

Countries citing papers authored by Yingbin Luo

Since Specialization
Citations

This map shows the geographic impact of Yingbin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingbin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingbin Luo more than expected).

Fields of papers citing papers by Yingbin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingbin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingbin Luo. The network helps show where Yingbin Luo may publish in the future.

Co-authorship network of co-authors of Yingbin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yingbin Luo. A scholar is included among the top collaborators of Yingbin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingbin Luo. Yingbin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yixin, Weiping Teng, Jianchun Wu, et al.. (2025). Piperlongumine Inhibits Lung Cancer Growth by Inducing Endoplasmic Reticulum Stress Leading to Suppression of M2 Macrophage Polarization. Biological Procedures Online. 27(1). 18–18. 2 indexed citations
2.
3.
Xu, Lili, Jianchun Wu, Jianhui Tian, et al.. (2025). Machine Learning Unveils Sphingolipid Metabolism's Role in Tumour Microenvironment and Immunotherapy in Lung Cancer. Journal of Cellular and Molecular Medicine. 29(7). e70435–e70435. 2 indexed citations
4.
Wu, Min, et al.. (2024). Radiomics based on MRI in predicting lymphovascular space invasion of cervical cancer: a meta-analysis. Frontiers in Oncology. 14. 1425078–1425078. 1 indexed citations
5.
Wang, Yuli, Yingbin Luo, Jianchun Wu, et al.. (2023). Elucidation of the anti-lung cancer mechanism of Juan-Liu-San-Jie prescription based on network pharmacology and experimental validation. Heliyon. 9(8). e18298–e18298. 1 indexed citations
6.
Zeng, Yaoying, Yingbin Luo, Bo Zhang, et al.. (2022). Solasonine Causes Redox Imbalance and Mitochondrial Oxidative Stress of Ferroptosis in Lung Adenocarcinoma. Frontiers in Oncology. 12. 874900–874900. 24 indexed citations
7.
Li, Bei, Yingbin Luo, Yixi Zhou, et al.. (2022). Role of sanguinarine in regulating immunosuppression in a Lewis lung cancer mouse model. International Immunopharmacology. 110. 108964–108964. 16 indexed citations
8.
Xu, Lili, Yingbin Luo, Jianhui Tian, et al.. (2022). A validated nomogram integrating baseline peripheral T-lymphocyte subsets and NK cells for predicting survival in stage I–IIIA non-small cell lung cancer after resection. Annals of Translational Medicine. 10(5). 250–250. 4 indexed citations
9.
Luo, Yingbin, Jianhui Tian, Zhihong Fang, et al.. (2022). Sanguinarine Regulates Tumor-Associated Macrophages to Prevent Lung Cancer Angiogenesis Through the WNT/β-Catenin Pathway. Frontiers in Oncology. 12. 732860–732860. 23 indexed citations
10.
Zeng, Yaoying, Yingbin Luo, Jianhui Tian, et al.. (2022). Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma. Medical Science Monitor. 28. e937131–e937131. 1 indexed citations
11.
Luo, Yingbin, Bo Zhang, Lili Xu, et al.. (2022). Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.. PubMed. 37(3). 269–285. 5 indexed citations
12.
Xu, Lili, Yuli Wang, Yingbin Luo, et al.. (2021). The Efficacy of Long-Term Chinese Herbal Medicine Use on Lung Cancer Survival Time: A Retrospective Two-Center Cohort Study with Propensity Score Matching. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 5 indexed citations
13.
Wang, Yuli, Yingbin Luo, Zhihong Fang, et al.. (2021). Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor Cells. Evidence-based Complementary and Alternative Medicine. 2021. 1–16. 6 indexed citations
14.
Wang, Yuli, Jianchun Wu, Lili Xu, et al.. (2021). Chinese Herbal Prescription Fu‐Zheng‐Qu‐Xie Prevents Recurrence and Metastasis of Postoperative Early‐Stage Lung Adenocarcinoma: A Prospective Cohort Study Followed with Potential Mechanism Exploration. Oxidative Medicine and Cellular Longevity. 2021(1). 6673828–6673828. 7 indexed citations
15.
Yu, Yuanyuan, Yingbin Luo, Zhihong Fang, et al.. (2020). <p>Mechanism of Sanguinarine in Inhibiting Macrophages to Promote Metastasis and Proliferation of Lung Cancer via Modulating the Exosomes in A549 Cells</p>. OncoTargets and Therapy. Volume 13. 8989–9003. 19 indexed citations
16.
Li, Honglin, Nan Huang, Jianchun Wu, et al.. (2018). Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2. BMC Cancer. 18(1). 579–579. 161 indexed citations
17.
Yang, Xiaohui, et al.. (2018). High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis. OncoTargets and Therapy. Volume 11. 3035–3046. 17 indexed citations
18.
Yang, Xiaohui, Jiabei Zhu, Jianchun Wu, et al.. (2018). (−)-Guaiol regulates autophagic cell death depending on mTOR signaling in NSCLC. Cancer Biology & Therapy. 19(8). 706–714. 20 indexed citations
19.
Li, He, et al.. (2017). The effect of <em>CYP2D6 *10</em> polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis. OncoTargets and Therapy. Volume 10. 5429–5437. 17 indexed citations
20.
Luo, Yingbin, Jianchun Wu, Xiaowen Zhu, et al.. (2016). NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula. Mediators of Inflammation. 2016. 1–7. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shreya Kar Breakdown of academic impact, for papers by Xiaokun Yang Breakdown of academic impact, for papers by Deok Yong Sim Breakdown of academic impact, for papers by Fengjun Cao Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Jianyong Xiao Breakdown of academic impact, for papers by Jing Ying Wang Breakdown of academic impact, for papers by Xuming Ji Breakdown of academic impact, for papers by Kaikai Yu Breakdown of academic impact, for papers by Wenjing Teng
Rankless by CCL
2026